Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The firm focuses on the development of product candidates to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. The company was founded by David Steinberg, Shaan C. Gandhi, and John L. Flavin on June 11, 2018 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
56
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Pyxis Oncology Inc market cap is $216.49M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pyxis Oncology Inc 52 week high is $5.55 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pyxis Oncology Inc 52 week low is $1.03 as of November 22, 2026.
Pyxis Oncology Inc stock price today is $1.81.
Pyxis Oncology Inc stock price yesterday was $1.68.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Pyxis Oncology Inc's P/E ratio is -1.4.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Pyxis Oncology Inc P/B ratio is 3.6582.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Pyxis Oncology Inc 50-day moving average is $2.13.